ICECURE MEDICAL LTD (ICCM) Stock Price & Overview
NASDAQ:ICCM • IL0011224156
Current stock price
The current stock price of ICCM is 0.3621 USD. Today ICCM is up by 0.86%. In the past month the price decreased by -42.38%. In the past year, price decreased by -69.82%.
ICCM Key Statistics
- Market Cap
- 29.395M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.25
- Dividend Yield
- N/A
ICCM Stock Performance
ICCM Stock Chart
ICCM Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ICCM. When comparing the yearly performance of all stocks, ICCM is a bad performer in the overall market: 96.54% of all stocks are doing better.
ICCM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ICCM. The financial health of ICCM is average, but there are quite some concerns on its profitability.
ICCM Earnings
On March 17, 2026 ICCM reported an EPS of -0.07 and a revenue of 1.28M. The company missed EPS expectations (-52.51% surprise) and missed revenue expectations (-34% surprise).
ICCM Forecast & Estimates
8 analysts have analysed ICCM and the average price target is 2.78 USD. This implies a price increase of 667.61% is expected in the next year compared to the current price of 0.3621.
For the next year, analysts expect an EPS growth of 24.52% and a revenue growth 105.15% for ICCM
ICCM Groups
Sector & Classification
ICCM Financial Highlights
Over the last trailing twelve months ICCM reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 16.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -108.42% | ||
| ROE | -166.36% | ||
| Debt/Equity | 0 |
ICCM Ownership
ICCM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 15.28 | 166.816B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.56 | 165.367B | ||
| SYK | STRYKER CORP | 22.37 | 129.577B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.49 | 90.642B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.03 | 46.953B | ||
| IDXX | IDEXX LABORATORIES INC | 39.37 | 46.307B | ||
| BDX | BECTON DICKINSON AND CO | 11.62 | 45.171B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.35 | 33.834B | ||
| RMD | RESMED INC | 18.42 | 32.944B | ||
| DXCM | DEXCOM INC | 25.41 | 24.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.26 | 18.482B | ||
| PODD | INSULET CORP | 30.98 | 13.912B | ||
| GMED | GLOBUS MEDICAL INC - A | 21.23 | 13.095B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ICCM
Company Profile
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Company Info
IPO: 2011-02-02
ICECURE MEDICAL LTD
7 Ha'eshel St., PO Box 3163
CAESAREA IL
CEO: EYAL SHAMIR
Employees: 68
Phone: 97246230333
ICECURE MEDICAL LTD / ICCM FAQ
What does ICCM do?
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
What is the stock price of ICECURE MEDICAL LTD today?
The current stock price of ICCM is 0.3621 USD. The price increased by 0.86% in the last trading session.
Does ICCM stock pay dividends?
ICCM does not pay a dividend.
What is the ChartMill technical and fundamental rating of ICCM stock?
ICCM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What sector and industry does ICECURE MEDICAL LTD belong to?
ICECURE MEDICAL LTD (ICCM) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How many employees does ICECURE MEDICAL LTD have?
ICECURE MEDICAL LTD (ICCM) currently has 68 employees.
What is the market capitalization of ICCM stock?
ICECURE MEDICAL LTD (ICCM) has a market capitalization of 29.40M USD. This makes ICCM a Nano Cap stock.